Q4FY21 Company Update - Pfizer Ltd - ICICI Direct

FY21 revenues grew 4.0% YoY to Rs. 2239 crore with hospital and vaccines business impacted amid the pandemic. EBITDA margins expanded 520 bps to 31.8% YoY due to a better overall operational performance. Decline in other expenses is likely on account of lower promotional and marketing activities related expenses. EBITDA grew 24.4% YoY to Rs. 712 crore. However, PAT de-grew 2.3% YoY to Rs. 498 crore. Delta vis-à-vis EBITDA was due to lower other income and tax reversals in the base year.

For details, click on the link below: Link to the report

Shares of PFIZER LTD. was last trading in BSE at Rs.5129.8 as compared to the previous close of Rs. 5133. The total number of shares traded during the day was 5783 in over 1363 trades.

The stock hit an intraday high of Rs. 5186.05 and intraday low of 5125. The net turnover during the day was Rs. 29731758.

Source : Equity Bulls

Keywords